• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AMO MANUFACTURING USA, LLC CATALYS SYSTEM; OPHTHALMIC FEMTOSECOND LASER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AMO MANUFACTURING USA, LLC CATALYS SYSTEM; OPHTHALMIC FEMTOSECOND LASER Back to Search Results
Model Number CATALYS-U
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Corneal Perforation (1792)
Event Date 04/27/2023
Event Type  Injury  
Manufacturer Narrative
Section h3: a review of records related to the device including labeling, complaint trending, and risk documentation will be performed.Upon completion of this review, if there is any further relevant information obtained, a supplemental medwatch will be filed.All pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.
 
Event Description
It was reported that one of the anterior penetrating arcuates fully penetrated the patients cornea due to patient movement.Doctor noticed this when he injected medication in the patient's eye.Doctor sutured the incision and completed procedure successfully.No additional information was provided.
 
Manufacturer Narrative
Correction: section h4: correction: in initial report, the manufacturer date provided was inadvertently reported as jan 12, 2017, however the correct date is jan 10, 2017.Additional information/device evaluation: section h3: device evaluated by manufacturer - yes.Section h4: correction: in initial report, the manufacturer date provided was inadvertently reported as oct 4, 2021, however the correct date is oct 7, 2021.Section h6; type of investigation - 3331, 4109.Section h6; investigation findings - 213.Section h6; investigation conclusions - 67.A review of the records related to this equipment that included labeling, manual, and risk documentation reviews for this equipment was performed.Equipment labeling provides possible complications that can be caused by the surgical/treatment procedure being performed.The trend review shows that there is not a recognizable adverse trend.The risks and mitigations associated with the complaint issue are identified in existing risk documents and no new risks were identified as part of this investigation.There was no product deficiency identified.All pertinent information available to johnson & johnson surgical vision has been submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CATALYS SYSTEM
Type of Device
OPHTHALMIC FEMTOSECOND LASER
Manufacturer (Section D)
AMO MANUFACTURING USA, LLC
510 cottonwood drive
milpitas CA 95035
Manufacturer Contact
somyata nagpal
31 technology drive
irvine, CA 92618
7142478552
MDR Report Key17099115
MDR Text Key316938980
Report Number3012236936-2023-01443
Device Sequence Number1
Product Code OOE
UDI-Device Identifier05050474609792
UDI-Public(01)05050474609792
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K113479
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 07/10/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/09/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberCATALYS-U
Device Catalogue NumberCATALYS-U
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received06/19/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/10/2017
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age68 YR
Patient SexMale
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-